Preferences and experiences with colorectal cancer screening methods
Official title: Exploring Participant Preference for Screening Methods and Experience Into Colorectal Cancer Screening Programme
Run by Advanced Marker Discovery S.l. · NCT06696534 · Data updated 2026-11-12
This test asks people aged 50–69 who completed a stool (FOBT) screen to share which colorectal cancer screening methods they prefer and how they experienced the screening program.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 50 Years to 69 Years |
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | Advanced Marker Discovery S.l. Industry-sponsored |
| Locations | 2 sites (Lisbon and 1 other locations) |
| Status | Recruiting |
| Started | May 19, 2025 |
| Main results expected | November 2025 |
| Study ends | December 2025 |
| Registry record updated | October 2, 2025 |
| Trial ID | NCT06696534 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are asymptomatic adults aged 50–69 invited to the local population-based screening program who have delivered a stool (FOBT) sample and can give informed consent.
✕Probably not a fit
People who have not provided a stool sample, who previously had a colonoscopy because of a positive FOBT, who are outside the 50–69 age range, symptomatic, or in a dependent relationship with the investigators or sponsor are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This low-risk interventional project invites adults aged 50–69 participating in a population-based colorectal screening program to complete two questionnaires about their screening experience and method preferences after undergoing a fecal occult blood test (FOBT). Participants provide informed consent and relevant clinical information from the screening visit is shared with study staff for analysis. Surveys are administered at participating primary care centers in Lisbon and Madrid to capture values, preferences, and reported experiences. Results will be analyzed to identify patterns that could inform how screening options and communications are offered to patients.
Why it matters
Potential benefit: If successful, the results could help programs offer screening methods and communications that better match patient preferences, potentially increasing participation and satisfaction.
How similar studies have gone: Questionnaire-based studies in colorectal screening programs have previously identified patient preferences that informed program design, so the approach is established though results vary by population.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Participants ages from 50 to 69 years (both included) at the time of informed consent signed. * Participants invited to participate in population-based screening programme who are eligible to undertake FOBT at the Primary Health Care Center. * Participants should sign an informed consent. They must understand the nature, significance, implications, and risks of the clinical study before signing the informed consent form. Exclusion Criteria: * Participants who have not delivery a stool sample in the Primary Health Care Center before signing the informed consent form. * Participants with a previous colonoscopy in consequence of a FOBT positive result. * Participants who are in a dependent personal or non-medical relationship with the Sponsor or the Investigators.
Where it's running
-
CS Mar Báltico
Madrid, Madrid, Spain Recruiting -
UCSP Sete Rios
Lisbon, Portugal Not yet recruiting
Study contacts
- Principal investigator: Maria A Perez, MD — Primary Health Care Centre Mar Báltico
- Study coordinator: Marta Jimenez, PhD
- Email: mjimenez@amadix.com
- Phone: +34 637899149
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Evaluating PreveCol for Early Detection of Colorectal Cancer
This study is testing a new blood test called PreveCol to see if it can help find colorectal cancer and advanced polyps in people aged 50-69 who have already had a positive stool test.
-
Types of persistent pain after hip or knee replacement
We will re-contact people who still have moderate-to-severe pain after hip or knee replacement to see whether their pain shows signs of nociceptive, neuropathic, or nociplastic mechanisms.
-
Evaluating a Turkish digital health readiness questionnaire for chronic diseases
This study tests a Turkish survey to see how ready people with chronic diseases are to use digital health tools to manage their conditions.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.